Clinical Trials Logo

Colorectal Cancer Stage IV clinical trials

View clinical trials related to Colorectal Cancer Stage IV.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06296056 Not yet recruiting - Clinical trials for Metastatic Colorectal Cancer

Phase I Study of Combined Immune Cell Therapy in Patients With Stage 4 Colorectal Cancer With Metastatic Lesion Who Failed Prior Standard of Care

Start date: June 1, 2024
Phase: Phase 1
Study type: Interventional

To evaluate the safety, immune response, and potential efficacy of combined immune cell therapy in patients with stage 4 colorectal cancer who have failed standard treatment and have unresectable lesions or metastatic lesions.

NCT ID: NCT05451719 Not yet recruiting - Colorectal Cancer Clinical Trials

Fruquintinib Plus Capecitabine Versus Capecitabine as Maintenance Therapy for Metastatic Colorectal Cancer After First-line Chemotherapy

Start date: July 2022
Phase: Phase 2
Study type: Interventional

This is an open-label, multicenter, randomized phase 2 study evaluating the efficacy and safety of fruquintinib plus capecitabine versus capecitabine as maintenance therapy for metastatic colorectal cancer after first-line treatment. Patients who have already achieved disease control (including CR/PR and SD) after ≥6 cycles of standard first-line induction treatment, and are still unresectable would be assigned into 2 maintenance treatment groups by randomization in a 1:1 ratio to receive fruquintinib + capecitabine or capecitabine. All patients will be treated until progressive disease, death from any cause, unacceptable toxicity or informed consent withdrawal.

NCT ID: NCT05289726 Not yet recruiting - Clinical trials for Colorectal Cancer Stage IV

Study on the Prevention of Dermal Toxicity Caused by Regorafenib by Traditional Chinese Medicine TDX105

Start date: April 18, 2022
Phase: Phase 2
Study type: Interventional

this is an preventive study to evaluate the preventive effect of traditional chinese medicine TDX105 on Regorafenib induced Dermatologic Toxicities

NCT ID: NCT04917276 Not yet recruiting - Clinical trials for Circulating Tumor Cell

Treatment Response Prediction System of mCRC Patients Based on CTC

Start date: June 15, 2021
Phase:
Study type: Observational

This study enrolling patients with metastatic colorectal cancer. Detecting CTC at different points in the treatment process. Descripting the molecular atlas of CTC in mCRC patients. Building and validating a response prediction system of mCTC patients.